Richard P. Butt

2.0k total citations
24 papers, 1.0k citations indexed

About

Richard P. Butt is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Richard P. Butt has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Surgery. Recurrent topics in Richard P. Butt's work include Pain Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Wound Healing and Treatments (4 papers). Richard P. Butt is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Wound Healing and Treatments (4 papers). Richard P. Butt collaborates with scholars based in United Kingdom, United States and Netherlands. Richard P. Butt's co-authors include Jill E. Bishop, Laurent Guy, Aoibhinn McDonnell, Geoffrey J. Laurent, Laura Iavarone, Susie M. Collins, Zahid Ali, Simon Kirby, Geert Jan Groeneveld and Guido van Amerongen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Neurology.

In The Last Decade

Richard P. Butt

23 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard P. Butt United Kingdom	18	458	232	213	194	143	24	1.0k
Yukinao Shibukawa Japan	21	622 1.4×	140 0.6×	138 0.6×	161 0.8×	45 0.3×	32	1.0k
Hyun Sook Kim South Korea	19	654 1.4×	153 0.7×	442 2.1×	110 0.6×	167 1.2×	65	1.2k
Harnath Shelat United States	19	543 1.2×	216 0.9×	158 0.7×	165 0.9×	167 1.2×	44	1.1k
Nancy Halnon United States	16	739 1.6×	98 0.4×	164 0.8×	432 2.2×	228 1.6×	47	1.4k
Tingting Yu China	19	651 1.4×	132 0.6×	81 0.4×	69 0.4×	76 0.5×	108	1.3k
Adriana Tavares United Kingdom	18	413 0.9×	109 0.5×	138 0.6×	199 1.0×	113 0.8×	78	1.3k
Chakib El-Moatassim France	9	673 1.5×	182 0.8×	234 1.1×	101 0.5×	111 0.8×	9	1.7k
Göknur Haliloğlu Türkiye	23	922 2.0×	189 0.8×	224 1.1×	161 0.8×	100 0.7×	116	1.7k
Christine Barnérias France	20	704 1.5×	113 0.5×	137 0.6×	65 0.3×	145 1.0×	73	1.4k

Countries citing papers authored by Richard P. Butt

Since Specialization

Citations

This map shows the geographic impact of Richard P. Butt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Butt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Butt more than expected).

Fields of papers citing papers by Richard P. Butt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Butt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Butt. The network helps show where Richard P. Butt may publish in the future.

Co-authorship network of co-authors of Richard P. Butt

This figure shows the co-authorship network connecting the top 25 collaborators of Richard P. Butt. A scholar is included among the top collaborators of Richard P. Butt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard P. Butt. Richard P. Butt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Román-Trufero, Mónica, Gavin A. Whitlock, Matthew J. Fuchter, et al.. (2024). Abstract 618: Preclinical assessment of APL-030, a selective and orally bioavailable inhibitor of the integrated stress response regulator GCN2 with activity against acute myeloid leukemia. Cancer Research. 84(6_Supplement). 618–618. 1 indexed citations

Amerongen, Guido van, Pieter Siebenga, Rachel Gurrell, et al.. (2019). Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans. British Journal of Anaesthesia. 123(2). e194–e203. 20 indexed citations

Siebenga, Pieter, Guido van Amerongen, Justin L. Hay, et al.. (2019). Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Na_v1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects. Clinical and Translational Science. 13(2). 318–324. 36 indexed citations

Siebenga, Pieter, Guido van Amerongen, William S. Denney, et al.. (2019). Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs. European Journal of Pain. 23(6). 1129–1140. 11 indexed citations

Gurrell, Rachel, Vivek Dua, Gang Feng, et al.. (2018). A randomised, placebo-controlled clinical trial with the α2/3/5 subunit selective GABAA positive allosteric modulator PF-06372865 in patients with chronic low back pain. Pain. 159(9). 1742–1751. 20 indexed citations

McDonnell, Aoibhinn, Susie M. Collins, Zahid Ali, et al.. (2018). Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy. Pain. 159(8). 1465–1476. 111 indexed citations

Amerongen, Guido van, Marieke L. de Kam, Jasper Stevens, et al.. (2016). The use of a battery of pain models to detect analgesic properties of compounds: a two‐part four‐way crossover study. British Journal of Clinical Pharmacology. 83(5). 976–990. 27 indexed citations

Jones, Hannah M., Richard P. Butt, Rob Webster, et al.. (2016). Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. Clinical Pharmacokinetics. 55(7). 875–887. 22 indexed citations

Shields, Shannon D., Richard P. Butt, Sulayman D. Dib‐Hajj, & Stephen G. Waxman. (2015). Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis. PLoS ONE. 10(3). e0119067–e0119067. 17 indexed citations

10.

McCormack, Ken, Mark L. Chapman, Douglas S. Krafte, et al.. (2013). Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels. Proceedings of the National Academy of Sciences. 110(29). E2724–32. 174 indexed citations

11.

Benson, Neil, Bart A. Ploeger, Carolyn Napier, et al.. (2010). Estimation of binding rate constants using a simultaneous mixed‐effects method: application to monoamine transporter reuptake inhibitor reboxetine. British Journal of Pharmacology. 160(2). 389–398. 14 indexed citations

12.

Fish, Paul V., Simon Bailey, Julian Blagg, et al.. (2007). Potent and Selective Nonpeptidic Inhibitors of Procollagen C-Proteinase. Journal of Medicinal Chemistry. 50(15). 3442–3456. 55 indexed citations

13.

Fish, Paul V., Chris Barber, David G. Brown, et al.. (2007). Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines. Journal of Medicinal Chemistry. 50(10). 2341–2351. 52 indexed citations

14.

Reid, Russell R., et al.. (2006). Inhibition of procollagen C‐proteinase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair and Regeneration. 14(2). 138–141. 33 indexed citations

15.

Ireland, Grenham W., et al.. (2005). A comparative study of the structure of human and murine greater omentum. Anatomy and Embryology. 209(3). 251–261. 86 indexed citations

16.

Butt, Richard P., J.P. Huggins, Doris Greiling, et al.. (2004). Discovery of potent and selective inhibitors of procollagen C‐proteinase for the treatment of fibrotic disorders. International Journal of Experimental Pathology. 85(1). 1 indexed citations

17.

Robins, Simon P., G. Todd Milne, Alexander Duncan, et al.. (2003). Increased Skin Collagen Extractability and Proportions of Collagen Type III Are Not Normalized after 6 Months Healing of Human Excisional Wounds. Journal of Investigative Dermatology. 121(2). 267–272. 52 indexed citations

18.

Bishop, Jill E., Richard P. Butt, K E Dawes, & G. Laurent. (1998). Mechanical Load Enhances the Stimulatory Effect of PDGF on Pulmonary Artery Fibroblast Procollagen Synthesis. CHEST Journal. 114(1). 25S–25S. 15 indexed citations

19.

Butt, Richard P. & Jill E. Bishop. (1997). Mechanical Load Enhances the Stimulatory Effect of Serum Growth Factors on Cardiac Fibroblast Procollagen Synthesis. Journal of Molecular and Cellular Cardiology. 29(4). 1141–1151. 95 indexed citations

20.

Butt, Richard P., Geoffrey J. Laurent, & Jill E. Bishop. (1995). Mechanical Load and Polypeptide Growth Factors Stimulate Cardiac Fibroblast Activity. Annals of the New York Academy of Sciences. 752(1). 387–393. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact